Skip to content

Public FDA record

Z-1289-2023: Trilogy Evo Universal Portable Electric Ventilator, Model Number DS2000X11B

Recall record Z-1289-2023 for Philips Respironics, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1289-2023
Company in FDA record
Philips Respironics, Inc.
FDA classification date
Apr 3, 2023
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class I

Reason stated in the source

The accuracy of delivered oxygen may deviate below the required tolerance of 5% from setpoint when providing high concentration oxygen therapy. Additionally, if equipped, the internal FiO2 sensor may indicate a value higher than the device is actually delivering. This may lead to under delivery of oxygen.

Source facts

Action
An URGENT Medical Device Correction notification letter dated 3/1/23 was sent to customers. Actions that should be taken by the user in order to prevent risks for patients. Until a solution is provided by Philips Respironics, patients prescribed Trilogy EV300, Trilogy Evo O2, or Trilogy Evo Universal that use high pressure oxygen, the following precautions must be observed: 1. Continuously monitor oximetry (SpO2) of the patient and follow your institution s protocol for monitoring of arterial blood gas measurements to ensure that the patient is receiving adequate oxygenation. 2. Use an external FiO2 monitor for any patient requiring FiO2 e70% to identify under delivery of oxygen. Switch to an alternative ventilator if an external FiO2 monitor is not available. 3. Maintain an immediately available back up device that will allow rapid transition to a different oxygen delivery method or alternative ventilator if monitoring suggests FiO2 is not being sufficiently delivered. Distribute this notice to all employees in your organization that need to be aware. Actions planned by Philips Respironics to correct the problem. Philips Respironics will release a software update that will address the issue. This software will be available free of charge to all Trilogy EV300, Trilogy Evo O2, and Trilogy Evo Universal users. Additional details will be provided when the update is available. In the interim, please take the actions above in order to prevent risk for your patients. If you need any further information or support concerning this issue, please contact your local Philips representative or Philips Respironics Customer Service at 1 (800) 345 6443.
Initiated
2023-03-01
Root cause
Under Investigation by firm
Distribution
Worldwide distribution. US Nationwide including Puerto Rico, and countries of AE, AR, AT, AU, BD, BE, BG, BO, BR, CA, CH, CL, CN, CO, CZ, DE, DK, EC, EE, EG, ES, FI, FR, GB, GE, GT, HK, HR, HU, ID, IL, IE, IN, IT, JP, KW, LB, LT, MM, MQ, MX, MY, NG, NL, NO, NP, NZ, PE, PF, PH, PK, PL, PT, QA, RO, RS, RU, SA, SG, SI, SK, TH, TR, TW, UA, VN, and ZA.
Recall number
Z-1289-2023
Recall status
Open, Classified
CDRH record ID
198966
FDA classified
2023-04-03
Recall event number
91832

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗